Personalised cancer vaccine reduces risk of disease recurrence in major trial

This announcement marks a significant advancement in cancer treatment, as a personalised vaccine has been shown to cut the risk of the disease returning in a major clinical trial. Scientists involved believe these results could represent a turning point, bringing personalised medicine closer to widespread use in oncology.

Originally published by bbc